Amrutanjan Health Care Limited — Important, 12-11-2024: Financial Result Updates

Amrutanjan Health Care Limited has announced a board meeting on November 12, 2024, approving the financial results for the quarter and half-year ended September 30, 2024.

Total revenue surged to ₹11,396.23 crore, reflecting a year-over-year growth of 10.3%, driven by increased demand and expansion in product lines, particularly in OTC Products and Women's Hygiene sectors.

Net profit for the period stood at ₹1,179.56 crore, a 72.4% increase compared to ₹684.92 crore last year, resulting in an EPS of ₹4.08. The rising profitability can be attributed to effective cost management and higher sales volumes.

Operational costs rose by 4.2% to ₹9,802.20 crore, signaling potential areas for efficiency improvements. The balance sheet reflects strong asset growth, with total assets up to ₹38,259.50 crore from ₹36,687.07 crore, and healthy cash flows improving liquidity.

Strategically, the company is focusing on expansion and product innovation, aligning with market sentiment favoring growth in the healthcare sector.

Investor insight leans towards a buy, considering robust revenue growth and profitability trends while monitoring operational efficiency and market expansion.